Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-11-30
1994-11-15
Chang, Celia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514212, 514316, 514317, 514327, 514330, 540590, 546189, 546208, 546217, 546225, 546227, 546236, 546240, A61K 31445, C07D21132, C07D40102
Patent
active
053648676
ABSTRACT:
4-Phenylpiperidines of the formula ##STR1## wherein R.sub.1 is hydrogen, hydroxy or lower-alkoxy;
REFERENCES:
patent: 2486794 (1949-11-01), Miescher et al.
patent: 2880211 (1959-03-01), Elpern
patent: 2898340 (1959-08-01), Janssen
patent: 2914532 (1959-11-01), Elpern
patent: 2951080 (1960-08-01), Pohland
patent: 2960507 (1960-11-01), Stern and Lawson
patent: 3024234 (1962-03-01), Stern
patent: 3043844 (1962-07-01), Elpern
patent: 3080372 (1963-03-01), Janssen
patent: 3141021 (1964-07-01), Janssen
patent: 3209006 (1965-09-01), Wragg et al.
patent: 3217009 (1965-11-01), Carabateas
patent: 3539580 (1970-11-01), Hermans and Verhoeven
patent: 3627772 (1971-12-01), Freter et al.
patent: 3674799 (1972-07-01), Edenhofer and Spiegelberg
patent: 3708597 (1973-01-01), Merz et al.
patent: 4022786 (1977-05-01), Hackmack and Klosa
patent: 4929734 (1990-05-01), Coughenour
patent: 5206249 (1993-04-01), Smith
Leander, J. D. & D. M. Zimmerman, "Antagonism of Bremazocine-Induced Urinaation as a Test for Kappa-Opioid Receptor Antagonists within the Phenylpiperidine Series" Drug Devel. Res. 4:421-427 (1984).
Glennon, R. A. et al., "Novel 1-Phenylpiperazine and 4-Phenylpiperidine Derivatives as High-Affinity Sigma Ligands", J. Med. Chem. 34:3360-3365 (1991).
DeHaven-Hudkins Diane L.
Mallamo John P.
Michne William F.
Chang Celia
DuPont Paul E.
Hake Richard A.
Sterling Winthrop Inc.
LandOfFree
4-phenylpiperdine agents for treating cns disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-phenylpiperdine agents for treating cns disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-phenylpiperdine agents for treating cns disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1097994